# Naproxen

NDC: 11534-211
Generic name: Naproxen
Labeler / Manufacturer: Sunrise Pharmaceutical, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: TABLET, DELAYED RELEASE
Routes: ORAL
Marketing started: 20251209

FDA application: ANDA091432

## Active ingredients

- NAPROXEN: 375 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"11534-211"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=11534-211
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=f2fb222a-b854-4e6f-9027-2e08aed24185